Pfizer (PFE) Shareholder Horan Capital Management Trimmed Its Stake; Abiomed (ABMD) Shareholder Juncture Wealth Strategies Lowered Its Position as Shares Rose

April 21, 2018 - By olga

ABIOMED, Inc. (NASDAQ:ABMD) Logo

Juncture Wealth Strategies Llc decreased its stake in Abiomed Inc (ABMD) by 54.86% based on its latest 2017Q4 regulatory filing with the SEC. Juncture Wealth Strategies Llc sold 5,362 shares as the company’s stock rose 49.46% while stock markets declined. The institutional investor held 4,412 shares of the health care company at the end of 2017Q4, valued at $827,000, down from 9,774 at the end of the previous reported quarter. Juncture Wealth Strategies Llc who had been investing in Abiomed Inc for a number of months, seems to be less bullish one the $13.55B market cap company. The stock decreased 0.17% or $0.53 during the last trading session, reaching $305.92. About 258,641 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 128.67% since April 21, 2017 and is uptrending. It has outperformed by 117.12% the S&P500.

Horan Capital Management decreased its stake in Pfizer Inc (PFE) by 4.73% based on its latest 2017Q4 regulatory filing with the SEC. Horan Capital Management sold 13,037 shares as the company’s stock declined 3.13% with the market. The institutional investor held 262,866 shares of the health care company at the end of 2017Q4, valued at $9.52 million, down from 275,903 at the end of the previous reported quarter. Horan Capital Management who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $217.90B market cap company. The stock increased 0.27% or $0.1 during the last trading session, reaching $36.63. About 21.23M shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 21, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Among 15 analysts covering Abiomed (NASDAQ:ABMD), 12 have Buy rating, 0 Sell and 3 Hold. Therefore 80% are positive. Abiomed had 35 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Tuesday, August 18 by Sterne Agee CRT. The stock has “Buy” rating by Jefferies on Thursday, December 21. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Friday, September 29 by SunTrust. The company was maintained on Friday, February 2 by Stephens. As per Thursday, June 29, the company rating was maintained by Jefferies. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Buy” rating given on Thursday, October 12 by Leerink Swann. The firm has “Hold” rating given on Tuesday, August 4 by BTIG Research. The firm has “Hold” rating given on Wednesday, August 5 by Piper Jaffray. Jefferies maintained it with “Buy” rating and $300.0 target in Thursday, February 1 report. The rating was maintained by Piper Jaffray with “Buy” on Thursday, February 1.

Analysts await ABIOMED, Inc. (NASDAQ:ABMD) to report earnings on May, 3 before the open. They expect $0.64 EPS, up 93.94% or $0.31 from last year’s $0.33 per share. ABMD’s profit will be $28.34 million for 119.50 P/E if the $0.64 EPS becomes a reality. After $0.70 actual EPS reported by ABIOMED, Inc. for the previous quarter, Wall Street now forecasts -8.57% negative EPS growth.

Since February 20, 2018, it had 0 insider purchases, and 1 insider sale for $5.41 million activity.

Investors sentiment decreased to 1.18 in 2017 Q4. Its down 0.12, from 1.3 in 2017Q3. It is negative, as 19 investors sold ABMD shares while 110 reduced holdings. 55 funds opened positions while 97 raised stakes. 36.44 million shares or 5.39% less from 38.51 million shares in 2017Q3 were reported. Sumitomo Mitsui Asset Mngmt owns 21,388 shares. Meeder Asset Mngmt accumulated 1,319 shares. Messner & Smith Theme Value Mngmt Ltd Ca invested 1.96% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Navellier Associates has 0.33% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 9,553 shares. Cibc World Mkts holds 0.01% or 9,091 shares. Scout Investments Incorporated stated it has 2.14% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Pub Employees Retirement Association Of Colorado reported 9,028 shares. Liberty Mutual Grp Inc Asset Mngmt holds 0.06% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 10,636 shares. Dynamic Capital Mngmt owns 2,756 shares. M&T Bancorporation Corp accumulated 1,184 shares or 0% of the stock. Morgan Stanley holds 0.02% or 310,773 shares in its portfolio. Cambridge Research Advisors Inc owns 8,787 shares. Janney Montgomery Scott Lc reported 1,786 shares. Granahan Inv Mngmt Incorporated Ma holds 84,562 shares or 1.25% of its portfolio. 21,894 were reported by Allen Management Limited Liability Com.

Since December 15, 2017, it had 0 buys, and 12 selling transactions for $12.99 million activity. Shares for $2.55M were sold by Dolsten Mikael. Shares for $353,677 were sold by LUND-JURGENSEN KIRSTEN. $1.52M worth of stock was sold by HILL CHARLES H on Tuesday, March 6. 50,000 Pfizer Inc. (NYSE:PFE) shares with value of $1.84M were sold by LANKLER DOUGLAS M. CORNWELL W DON sold $64,679 worth of stock. $998,666 worth of Pfizer Inc. (NYSE:PFE) shares were sold by JOHNSON RADY A.

Horan Capital Management, which manages about $446.88M and $503.45M US Long portfolio, upped its stake in Chipotle Mexican Grill Inc Cl A (NYSE:CMG) by 3,293 shares to 15,864 shares, valued at $4.59 million in 2017Q4, according to the filing.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1 before the open. They expect $0.73 EPS, up 5.80% or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34 billion for 12.54 P/E if the $0.73 EPS becomes a reality. After $0.62 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74% EPS growth.

ABIOMED, Inc. (NASDAQ:ABMD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>